ASE invites you to submit your basic or clinical research for a chance to present in paradise at the 34th Annual Echo Hawaii meeting in January 2025!
Research and abstracts that have previously been presented at another meeting are welcome. Presenters should also note that abstracts accepted to this meeting are not published. As such, presentation of your work at Echo Hawaii may not interfere with its future presentation at another national meeting.
Submit Your Research Here
Selection for Presentation
Submitted abstracts are peer-reviewed by a panel of graders. Selection for presentation is based solely on scientific merit. Accepted abstracts will be presented as a poster on the evening of Tuesday, January 21, 2024. During presentation, members of the faculty will moderate your work, allowing you an opportunity to briefly present your key findings for commentary from our internationally renowned faculty.
Submission & Presentation Guidelines
General Information
- Authors do not need to be ASE members to participate.
- Individuals can submit no more than two (2) abstracts as first author.
- Abstract submission is free of charge. However, any expenses (e.g., registration, airfare, lodging, etc.) associated with the submission and presentation of an abstract are the sole responsibility of the presenter.
- Echo Hawaii only accepts abstracts of basic or clinical research. Case reports are not considered for presentation.
- Submission of an abstract constitutes a commitment by the author(s) to present if accepted. Presenting authors are expected to register for the Echo Hawaii meeting within two weeks of acceptance notification, or risk forfeiting their presentation assignment.
Submission Details & Deadlines
- Abstract submission opens Tuesday, September 3, 2024.
- Abstracts must be submitted in their final form by 11:59 PM Eastern Time on Tuesday, October 1, 2024.
- Authors must follow all instructions for completing their submission.
- ASE is not responsible for work that is not submitted by the submission deadline. No new abstracts will be accepted after the submission deadline.
Author Name(s) and Affiliation(s)
- Abstracts must include the first and last names for all authors. Do not list authors by initial only.
- All authors are required to comply with ASE’s Disclosure Policy, and are expected to disclose any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing medical education activity. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, and/or other corporations whose products or services are related to the subject matter of the research topic.
- If an abstract is accepted for presentation, the presenter must be one of the authors listed on the submission.
Content and Format
- Character limit – Abstracts are limited to 500 words. This includes the text, but not the title or authors.
- Tables/Graphics – The use of up to two (2) tables and/or graphics is encouraged if they are relevant to the research submitted. These images can either be embedded within your abstract file or submitted as separate attachments.
- Abbreviations – A maximum of five (5) unique abbreviations is allowed within the body of the abstract.
- Format – Content must be structured into the following four (4) sections:
- Background:
- Methods:
- Results:
- Conclusion:
- Clarity of expression will be considered in the review process. The overall quality of language used should assure comprehension by the reader.
- Do not include:
- References for credits.
- Names or personal information of any patient participating in the study or trial. If you do, the abstract will not be considered for presentation.
- Authors or institutions in the title.
- Proofread abstracts carefully to avoid errors.
Eligibility
- Any human experimentation must conform to the principles of the Declaration of Helsinki of the World Medical Association.
- ASE endorses the position of the American Association for the Advancement of Science (AAAS) in requiring assurances of the responsible use of animals in research. All submissions for consideration must be in compliance with these guidelines (AAAS Resolution: Use of Animals in Research, Testing, and Education).
Presentation
- All accepted abstracts will be presented as a moderated poster.
- All presentations and question-and-answer periods will be in English. If presenters need assistance in understanding or responding to questions in English, they are encouraged to have a member of their research team assist them.
- Each presenting author is required to comply with ASE’s Disclosure Policy, and is expected to disclose to the audience any real or apparent conflicts(s) of interest that may have a direct bearing on the subject matter of the continuing medical education activity. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic.
Disclosure
- All abstracts submitted to Echo Hawaii are disclosed to members of the peer-review selection committee, as well as to ASE employees and contractors as necessary in connection with the 34th Annual Echo Hawaii program. Notwithstanding these policies and procedures, ASE is not subject to any confidentiality requirements with respect to submitted abstracts. In addition, compliance with any disclosure or nondisclosure requirements that apply to researchers or research sponsors (whether under federal securities laws, contract agreement, or otherwise) is the sole responsibility of the researcher and/or sponsor, and not ASE.
Abstract Withdrawal
- Abstract withdrawal requests should be emailed to EHabstracts@ASEcho.org. Include your abstract title and the presenting author’s name in your email.
Questions about the submission process?
- Contact Chloe Kattau at EHabstracts@ASEcho.org.